Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

Misfolded proteins in Alzheimer’s disease and Parkinson’s disease follow a well-defined connectomics-based spatial progression. Several anti-tau and anti-alpha synuclein (aSyn) antibodies have failed to provide clinical benefit in clinical trials despite substantial target engagement in the experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Geerts, Hugo, Bergeler, Silke, Walker, Mike, van der Graaf, Piet H., Courade, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474108/
https://www.ncbi.nlm.nih.gov/pubmed/37658103
http://dx.doi.org/10.1038/s41598-023-41382-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474108/
https://www.ncbi.nlm.nih.gov/pubmed/37658103
http://dx.doi.org/10.1038/s41598-023-41382-0

Ejemplares similares